1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Upper Extremity Medical Exoskeleton Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Upper Extremity Medical Exoskeleton by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Upper Extremity Medical Exoskeleton by Country/Region, 2020, 2024 & 2031
2.2 Upper Extremity Medical Exoskeleton Segment by Type
2.2.1 Mobile Exoskeletons
2.2.2 Stationary Exoskeletons
2.3 Upper Extremity Medical Exoskeleton Sales by Type
2.3.1 Global Upper Extremity Medical Exoskeleton Sales Market Share by Type (2020-2025)
2.3.2 Global Upper Extremity Medical Exoskeleton Revenue and Market Share by Type (2020-2025)
2.3.3 Global Upper Extremity Medical Exoskeleton Sale Price by Type (2020-2025)
2.4 Upper Extremity Medical Exoskeleton Segment by Application
2.4.1 Rehabilitation Centers
2.4.2 Physiotherapy Centers
2.4.3 Hospital
2.4.4 Others
2.5 Upper Extremity Medical Exoskeleton Sales by Application
2.5.1 Global Upper Extremity Medical Exoskeleton Sale Market Share by Application (2020-2025)
2.5.2 Global Upper Extremity Medical Exoskeleton Revenue and Market Share by Application (2020-2025)
2.5.3 Global Upper Extremity Medical Exoskeleton Sale Price by Application (2020-2025)
3 Global Upper Extremity Medical Exoskeleton by Company
3.1 Global Upper Extremity Medical Exoskeleton Breakdown Data by Company
3.1.1 Global Upper Extremity Medical Exoskeleton Annual Sales by Company (2020-2025)
3.1.2 Global Upper Extremity Medical Exoskeleton Sales Market Share by Company (2020-2025)
3.2 Global Upper Extremity Medical Exoskeleton Annual Revenue by Company (2020-2025)
3.2.1 Global Upper Extremity Medical Exoskeleton Revenue by Company (2020-2025)
3.2.2 Global Upper Extremity Medical Exoskeleton Revenue Market Share by Company (2020-2025)
3.3 Global Upper Extremity Medical Exoskeleton Sale Price by Company
3.4 Key Manufacturers Upper Extremity Medical Exoskeleton Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Upper Extremity Medical Exoskeleton Product Location Distribution
3.4.2 Players Upper Extremity Medical Exoskeleton Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Upper Extremity Medical Exoskeleton by Geographic Region
4.1 World Historic Upper Extremity Medical Exoskeleton Market Size by Geographic Region (2020-2025)
4.1.1 Global Upper Extremity Medical Exoskeleton Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Upper Extremity Medical Exoskeleton Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Upper Extremity Medical Exoskeleton Market Size by Country/Region (2020-2025)
4.2.1 Global Upper Extremity Medical Exoskeleton Annual Sales by Country/Region (2020-2025)
4.2.2 Global Upper Extremity Medical Exoskeleton Annual Revenue by Country/Region (2020-2025)
4.3 Americas Upper Extremity Medical Exoskeleton Sales Growth
4.4 APAC Upper Extremity Medical Exoskeleton Sales Growth
4.5 Europe Upper Extremity Medical Exoskeleton Sales Growth
4.6 Middle East & Africa Upper Extremity Medical Exoskeleton Sales Growth
5 Americas
5.1 Americas Upper Extremity Medical Exoskeleton Sales by Country
5.1.1 Americas Upper Extremity Medical Exoskeleton Sales by Country (2020-2025)
5.1.2 Americas Upper Extremity Medical Exoskeleton Revenue by Country (2020-2025)
5.2 Americas Upper Extremity Medical Exoskeleton Sales by Type
5.3 Americas Upper Extremity Medical Exoskeleton Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Upper Extremity Medical Exoskeleton Sales by Region
6.1.1 APAC Upper Extremity Medical Exoskeleton Sales by Region (2020-2025)
6.1.2 APAC Upper Extremity Medical Exoskeleton Revenue by Region (2020-2025)
6.2 APAC Upper Extremity Medical Exoskeleton Sales by Type
6.3 APAC Upper Extremity Medical Exoskeleton Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Upper Extremity Medical Exoskeleton by Country
7.1.1 Europe Upper Extremity Medical Exoskeleton Sales by Country (2020-2025)
7.1.2 Europe Upper Extremity Medical Exoskeleton Revenue by Country (2020-2025)
7.2 Europe Upper Extremity Medical Exoskeleton Sales by Type
7.3 Europe Upper Extremity Medical Exoskeleton Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Upper Extremity Medical Exoskeleton by Country
8.1.1 Middle East & Africa Upper Extremity Medical Exoskeleton Sales by Country (2020-2025)
8.1.2 Middle East & Africa Upper Extremity Medical Exoskeleton Revenue by Country (2020-2025)
8.2 Middle East & Africa Upper Extremity Medical Exoskeleton Sales by Type
8.3 Middle East & Africa Upper Extremity Medical Exoskeleton Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Upper Extremity Medical Exoskeleton
10.3 Manufacturing Process Analysis of Upper Extremity Medical Exoskeleton
10.4 Industry Chain Structure of Upper Extremity Medical Exoskeleton
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Upper Extremity Medical Exoskeleton Distributors
11.3 Upper Extremity Medical Exoskeleton Customer
12 World Forecast Review for Upper Extremity Medical Exoskeleton by Geographic Region
12.1 Global Upper Extremity Medical Exoskeleton Market Size Forecast by Region
12.1.1 Global Upper Extremity Medical Exoskeleton Forecast by Region (2026-2031)
12.1.2 Global Upper Extremity Medical Exoskeleton Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Upper Extremity Medical Exoskeleton Forecast by Type
12.7 Global Upper Extremity Medical Exoskeleton Forecast by Application
13 Key Players Analysis
13.1 B-Temia
13.1.1 B-Temia Company Information
13.1.2 B-Temia Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.1.3 B-Temia Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 B-Temia Main Business Overview
13.1.5 B-Temia Latest Developments
13.2 Rex Bionics
13.2.1 Rex Bionics Company Information
13.2.2 Rex Bionics Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.2.3 Rex Bionics Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rex Bionics Main Business Overview
13.2.5 Rex Bionics Latest Developments
13.3 Cyberdyne
13.3.1 Cyberdyne Company Information
13.3.2 Cyberdyne Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.3.3 Cyberdyne Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cyberdyne Main Business Overview
13.3.5 Cyberdyne Latest Developments
13.4 LockHeed Martin
13.4.1 LockHeed Martin Company Information
13.4.2 LockHeed Martin Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.4.3 LockHeed Martin Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 LockHeed Martin Main Business Overview
13.4.5 LockHeed Martin Latest Developments
13.5 Ekso Bionics Holdings
13.5.1 Ekso Bionics Holdings Company Information
13.5.2 Ekso Bionics Holdings Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.5.3 Ekso Bionics Holdings Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ekso Bionics Holdings Main Business Overview
13.5.5 Ekso Bionics Holdings Latest Developments
13.6 Myomo
13.6.1 Myomo Company Information
13.6.2 Myomo Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.6.3 Myomo Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Myomo Main Business Overview
13.6.5 Myomo Latest Developments
13.7 ExoAtlet Global S.A
13.7.1 ExoAtlet Global S.A Company Information
13.7.2 ExoAtlet Global S.A Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.7.3 ExoAtlet Global S.A Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ExoAtlet Global S.A Main Business Overview
13.7.5 ExoAtlet Global S.A Latest Developments
13.8 Parker Hannifin
13.8.1 Parker Hannifin Company Information
13.8.2 Parker Hannifin Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.8.3 Parker Hannifin Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Parker Hannifin Main Business Overview
13.8.5 Parker Hannifin Latest Developments
13.9 GOGOA Mobility Robots
13.9.1 GOGOA Mobility Robots Company Information
13.9.2 GOGOA Mobility Robots Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.9.3 GOGOA Mobility Robots Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GOGOA Mobility Robots Main Business Overview
13.9.5 GOGOA Mobility Robots Latest Developments
13.10 Alter G
13.10.1 Alter G Company Information
13.10.2 Alter G Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.10.3 Alter G Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Alter G Main Business Overview
13.10.5 Alter G Latest Developments
13.11 Hocoma
13.11.1 Hocoma Company Information
13.11.2 Hocoma Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.11.3 Hocoma Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hocoma Main Business Overview
13.11.5 Hocoma Latest Developments
13.12 Hyundai
13.12.1 Hyundai Company Information
13.12.2 Hyundai Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.12.3 Hyundai Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hyundai Main Business Overview
13.12.5 Hyundai Latest Developments
13.13 Wandercraft and Wearable Robotics
13.13.1 Wandercraft and Wearable Robotics Company Information
13.13.2 Wandercraft and Wearable Robotics Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.13.3 Wandercraft and Wearable Robotics Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wandercraft and Wearable Robotics Main Business Overview
13.13.5 Wandercraft and Wearable Robotics Latest Developments
13.14 ReWalk Robotics
13.14.1 ReWalk Robotics Company Information
13.14.2 ReWalk Robotics Upper Extremity Medical Exoskeleton Product Portfolios and Specifications
13.14.3 ReWalk Robotics Upper Extremity Medical Exoskeleton Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 ReWalk Robotics Main Business Overview
13.14.5 ReWalk Robotics Latest Developments
14 Research Findings and Conclusion
※参考情報 医療用上肢外骨格(Upper Extremity Medical Exoskeleton)は、主にリハビリテーションや運動機能の向上を目的として開発された装置で、上肢に装着することによって、身体の自由度を高めたり、作業を支援したりする役割を果たします。この外骨格技術は、主に神経系の損傷や病気、一般的な運動機能の低下などに悩む患者に対して、補助的な手段を提供するものです。 医療用上肢外骨格の定義は、基本的には人間の身体に装着する機械的な装置であり、骨格を模倣した構造を持ち、人間の動作を補助するために設計されています。この外骨格は、下肢用のものと同様に、人工的な筋肉や関節の動きによって患者の動作を支援します。 特徴として、まず第一に考えられるのは、随意運動を助けるためのセンサーやモーター技術です。これにより、患者は意識的に運動を試みることができ、その際に外骨格が適切にサポートを提供します。また、軽量設計であることも重要な要素です。装置が重すぎると、患者の負担が増え、リハビリテーションの効果が低下する可能性があるため、製造時には常にこの点が考慮されています。 種類については、主に以下のようなものがあります。まず、完全自動型の外骨格があります。これは、障害やケガのために上肢の運動ができない患者に対して、全自動で動作を支援するものです。次に、半自動型の外骨格があります。これは、患者が自らの意志で動作を試みる際に、追加的なサポートを提供するために使用されます。最後に、装着型リハビリテーションデバイスもあり、特定のトレーニングや治療プログラムに合わせて設計されたものです。 用途に関しては、医療用上肢外骨格は主にリハビリテーションに用いられます。脳卒中や外傷性脳損傷を経験した患者は、上肢の運動機能が低下していることが多く、これらの患者にとって、この技術は非常に重要です。また、脊髄損傷や筋ジストロフィーなどの疾患によって運動機能が制限されている方々にも利用されています。さらに、加齢に伴う運動能力の低下を支援するためにも利用されることがあります。 関連技術としては、センサー技術や、人工知能(AI)、機械学習があります。これらの技術は、患者の動作や反応をリアルタイムで分析し、外骨格の制御にフィードバックを提供します。特に、機械学習を用いることで、患者ごとの特性や進行度に応じた最適なサポートを提供することが可能になります。また、バイオメカニクスに関する知識も、この技術の設計や開発において重要な要素となります。身体の解剖学や生理学に基づいた設計が求められます。 医療用上肢外骨格は、今後ますます多様化・高度化していくことが期待され、特に高齢化社会において、その需要はますます高まっていくと考えられます。また、リハビリテーションの現場における導入が進むことで、より多くの患者がこの技術の恩恵を受けられるようになるでしょう。しかし、この技術の普及にはまだ課題も多く、価格や訓練の必要性、さらには倫理的な問題も含めて、様々な側面からの検討が求められています。医療従事者や研究者、技術者が協力し、実用性を高めていくことで、医療用上肢外骨格の未来が切り開かれることを期待しています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/